Schedule 13D ownership disclosure

Tenaya Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 87990A106

Event date: 2025-03-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Casdin Capital, LLCReported CIK 0001534261

    Shares: 6,732,971.00 · Class: 4.3%

  • Casdin Partners Master Fund, L.P.Reported CIK 0001534265

    Shares: 6,371,002.00 · Class: 4.1%

  • Casdin Partners GP, LLCReported CIK 0001534260

    Shares: 6,371,002.00 · Class: 4.1%

  • Eli CasdinReported CIK 0001534264

    Shares: 6,732,971.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-001872
Form type
SCHEDULE 13D/A
Filer
Casdin Capital, LLC
CIK
CIK 1534261
Filed
Mar 07, 2025
Reporting period
Mar 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub